Investor Presentaiton
Investor presentation
First nine months of 2018
9M 2018 sales decreased by 2% in Danish kroner and
increased by 4% in local currencies to DKK 82.1 billion
Reported sales and local currency
growth by region
Reported sales and local currency
growth by therapy
Slide 23
bDKK
bDKK
International Operations regions
Diabetes
Biopharm
45
1%
8%
40
760
70
4%
60
35
50
30
(1%)
40
25
20
30
2%
15
20
18%
10-
14%
8%
(1%)
10
5
(3%)
(3%)
35%
5%
53%
0
0
NAO
IO
Region Region Region Region Region
Europe AAMEO China J&K LATAM
Diabetes Insulin
GLP-1 Obesity Bio-
pharm
Haemo- Growth
philia disorders
NAO: North America Operations; IO: International Operations; LATAM: Latin America; AAMEO: Africa, Asia,
Middle East & Oceania; J&K: Japan & Korea; 9M: First nine months of 2018View entire presentation